Molecular mechanisms and therapeutic strategies of chronic renal injury: The role of nuclear factor κB activation in the development of renal fibrosis

Journal of Pharmacological Sciences

Volumn 100, Issue 1, 2006, Pages 17-21

  Tamada, Satoshi ^a   Asai, Toshihiro ^a   Kuwabara, Nobuyuki ^a   Iwai, Tomoaki ^a   Uchida, Junji ^a   Teramoto, Kae ^a   Kaneda, Noriko ^a   Yukimura, Tokihito ^a   Komiya, Toshiyuki ^b   Nakatani, Tatsuya ^a   Miura, Katsuyuki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kitano Hospital   (Japan)

Author keywords

Nephrotoxicity; Nuclear factor B; Oral adsorbent; Renal fibrosis; Unilateral ureteral obstruction

Indexed keywords

ADSORBENT; AST 120; CYCLOSPORIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDICAN; TACROLIMUS;

CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DISEASE COURSE; HYPOMAGNESEMIA; INFLAMMATION; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUBULE CELL; MACROPHAGE; MOLECULAR MECHANICS; NEPHRITIS; NEPHROTOXICITY; NONHUMAN; PROTEIN FUNCTION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY;

EID: 31544450737     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FMJ05003X4     Document Type: Short Survey

References (21)

1. Nath KA. The tubulointerstitium in progressive renal disease. Kidney Int. 1998;54:992-994.
2. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066-1071.
3. Burdmann EA, Andoh TF, Lindsley J, Houghton DC, Bennett WM. Effects of oral magnesium supplementation on acute experimental cyclosporin nephrotoxicity. Nephrol Dial Transplant. 1994;9:16-21.
4. Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int. 1996;50:1110-1117.
5. Rob PM, Lebeau A, Nobiling R, Schmid H, Bley N, Dick K, et al. Magnesium metabolism: basic aspects and implications of ciclosporine toxicity in rats. Nephron. 1996;72:59-66.
6. Pere AK, Lindgren L, Tuomainen P, Krogerus L, Rauhala P, Laakso J, et al. Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity. Kidney Int. 2000;58:2462-2472.
7. Miura K, Nakatani T, Asai T, Yamanaka S, Tamada S, Tashiro K, et al. Role of hypomagnesemia in chronic cyclosporine nephropathy. Transplantation. 2002;73:340-347.
8. Asai T, Nakatani T, Yamanaka S, Tamada S, Kishimoto T, Tashiro K, et al. Magnesium supplementation prevents experimental chronic cyclosporine A nephrotoxicity via renin-angiotensin system independent mechanism. Transplantation. 2002;74:784-791.
9. Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int. 1991;39:550-556.
10. Asai T, Nakatani T, Tamada S, Kuwabara N, Yamanaka S, Tashiro K, et al. Activation of transcription factors AP-1 and NF-κB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation. Transplantation. 2003;75:1040-1044.
11. Tamada S, Nakatani T, Asai T, Tashiro K, Komiya T, Sumi T, et al. Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy. Kidney Int. 2003;63:306-314.
12. Baldwin AS Jr. The NF-κB and I κB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-683.
13. DiDonato J, Mercurio F, Rosette C, Wu-Li J, Suyang H, Ghosh S, et al. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol. 1996;16:1295-1304.
14. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell. 1996;84:853-862.
15. Klahr S, Harris K, Purkerson ML. Effects of obstruction on renal functions. Pediatr Nephrol. 1988;2:34-42.
16. Nakatani T, Tamada S, Asai T, Iwai Y, Kim T, Tsujino T, et al. Role of renin-angiotensin system and nuclear factor-κB in the obstructed kidney of rats with unilateral ureteral obstruction. Jpn J Pharmacol. 2002;90:361-364.
17. Tashiro K, Tamada S, Kuwabara N, Komiya T, Takekida K, Asai T, et al. Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor κB. Int J Mol Med. 2003;12:587-592.
18. Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, et al. Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure. Kidney Int. 1991;40:461-469.
19. Niwa T, Miyazaki T, Hashimoto N, Hayashi H, Ise M, Uehara Y, et al. Suppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats. Am J Nephrol. 1992;12:201-206.
20. Yoshida Y, Sakai T, Ise M. Effects of oral adsorbent in the rat model of chronic renal failure. Nephron. 1992;62:305-314.
21. Motojima M, Hosokawa A, Yamato H, Muraki T, Yoshioka T. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-κB and free radical in proximal tubular cells. Kidney Int. 2003;63:1671-1680.